Nicox has announced an agreement with GHO Capital, a London-based specialist investor in health care, to transfer its commercial operations to a new private company focusing on the commercialization of ophthalmic products in Europe. Under the terms of the transaction, which awaits completion, Nicox will assign rights to its European ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.